PDF herunterladen
Pharmacopsychiatry 2019; 52(04): e1
DOI: 10.1055/a-1123-8803
Erratum
© Georg Thieme Verlag KG Stuttgart · New York

Correction: Comparing Schizophrenia Patients With a Predicted High/Low Risk of Nonresponse Receiving Treatment with Ziprasidone and Haloperidol: A Randomized-Controlled Study

Authors

  • Rebecca Schennach

    1   Department of Psychiatry, Ludwig-Maximilians-University, Munich, Germany
    5   Schoen Clinic Roseneck, Prien am Chiemsee, Germany

  • Michael Riedel

    1   Department of Psychiatry, Ludwig-Maximilians-University, Munich, Germany
    6   Psychiatric Clinic Rodewisch, Rodewisch, Germany

  • Ilja Spellmann

    1   Department of Psychiatry, Ludwig-Maximilians-University, Munich, Germany
    7   Psychiatric Clinic, Stuttgart, Germany

  • Richard Musil

    1   Department of Psychiatry, Ludwig-Maximilians-University, Munich, Germany

  • Michael Obermeier

    1   Department of Psychiatry, Ludwig-Maximilians-University, Munich, Germany

  • Markus Jäger

    1   Department of Psychiatry, Ludwig-Maximilians-University, Munich, Germany
    8   Psychiatric Clinic, District Hospital Kempten, Kempten, Germany

  • Roland Bottlender

    2   Psychiatric Clinic, District Hospital Lüdenscheid, Lüdenscheid, Germany

  • Max Schmauss

    3   Psychiatric Clinic, District Hospital Augsburg, Augsburg, Germany

  • Gerd Laux

    4   Psychiatric Clinic, Inn-Salzach Hospital Wasserburg/Inn, Wasserburg, Germany

  • Hans-Jürgen Möller

    1   Department of Psychiatry, Ludwig-Maximilians-University, Munich, Germany
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
26. Februar 2020 (online)

Auch verfügbar auf